TP53 and cervical cancer: In order to validate the ability of this assay to specifically identify compounds capable of impairing the E6-mediated degradation of p53, we tested two small molecules (SAHA and RITA) that were reported to rescue p53 from the degradation induced by E6 in cervical cancer cells.